Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Torulopsis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1703 Neoplasms 1222 Carcinoma, Non-Small-Cell Lung 1109 Prostatic Neoplasms 914 Multiple Myeloma 707 Leukemia, Myeloid, Acute 638 Neoplasm Metastasis 599 Colorectal Neoplasms 592 Lung Neoplasms 583 Melanoma 563 Lymphoma 538 Leukemia 495 Lymphoma, Non-Hodgkin 476 Ovarian Neoplasms 449 Leukemia, Lymphocytic, Chronic, B-Cell 444 Pancreatic Neoplasms 422 Precursor Cell Lymphoblastic Leukemia-Lymphoma 404 Recurrence 388 Myelodysplastic Syndromes 349 Carcinoma, Renal Cell 346 Lymphoma, Follicular 345 Head and Neck Neoplasms 328 Brain Neoplasms 318 Glioblastoma 317 Lymphoma, Large B-Cell, Diffuse 310 Carcinoma, Hepatocellular 282 Hodgkin Disease 280 Squamous Cell Carcinoma of Head and Neck 261 Lymphoma, Mantle-Cell 255 Colonic Neoplasms 235

Interventions

PRA1 protein, Candida albicans 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00569231 2011-01-25

Study With Candida Antigen for Treatment of Warts

University of Arkansas

Phase 1 Completed

18 enrolled 8 charts

Torulopsis, Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡